Nuclear medicine equipment refers to specialized medical devices that use radioactive substances (radiopharmaceuticals) for diagnosing, treating, and managing various diseases. These systems visualize physiological processes within the body, helping clinicians detect abnormalities such as tumors, heart disease, and neurological disorders at an early stage.
Nuclear medicine is increasingly used for targeted radiation therapy, where radioactive isotopes deliver radiation directly to tumors, minimizing side effects. With continuous advancements in AI, automation, and patient-friendly designs, nuclear medicine equipment is becoming smarter, faster, and more accessible to global healthcare providers.
According to BIS Research, global nuclear medicine equipment market was valued at $6.12 billion in 2023 and is expected to grow significantly in the next 10 years, driven by rising disease prevalence and the rapid adoption of AI-integrated imaging solutions.
• Rising Prevalence of Chronic Diseases: Increasing global cases of cancer, cardiovascular diseases, and neurological disorders are fueling the demand for accurate, early-stage diagnostic systems.
• Technological Advancements in Imaging: Innovations in hybrid systems such as PET/CT and SPECT/CT provide enhanced image resolution and diagnostic confidence, improving patient outcomes.
• Artificial Intelligence and Machine Learning Integration: AI algorithms now automate image interpretation, enhance accuracy, and support personalized treatment planning by correlating imaging data with patient history.
• Shift Toward Personalized Medicine: Molecular imaging enables clinicians to tailor therapies based on disease progression and individual patient profiles.
• Government and Private Investments in Healthcare Infrastructure: Expanding imaging facilities and favorable reimbursement policies in developed regions are accelerating market adoption.
• High Capital and Operational Costs: PET/CT and SPECT/CT systems require substantial upfront investment, maintenance, and operational budgets—posing challenges for smaller hospitals and developing economies.
• Limited Reimbursement and Infrastructure: Inadequate coverage for nuclear medicine procedures and lack of specialized facilities to restrict adoption in low- and middle-income regions.
• Short Half-Life of Radiopharmaceuticals: Logistical constraints in isotope production and transport hinder consistent availability of nuclear tracers.
• Shortage of Skilled Professionals: The lack of trained radiologists and nuclear technologists impacts imaging quality and workflow efficiency.
• Cardiology
• Oncology
• Neurology
• Other Applications
• Hospitals
• Imaging Centres
• Academic and Research Centres
• Other End Users
• North America
• Europe
• Asia-Pacific
• Rest of the World
Explore the Full TOC and Download Report Sample >>
The global nuclear medicine equipment market is entering a transformative phase where AI, hybrid imaging, and radiopharmaceutical advancements converge to redefine diagnostics and therapy. As healthcare shifts toward precision medicine, cost-effective solutions and automation-driven imaging will be key to expanding global access. The next decade will favor companies focusing on integrated, AI-enhanced, and patient-centric technologies.
-BIS Research Analyst Team
North America will lead, while Asia-Pacific will see the fastest growth due to expanding healthcare infrastructure.
Siemens Healthineers, GE Healthcare, Philips, Canon Medical, Mediso, and Digirad dominate global market share.
AI/ML-powered imaging analytics, hybrid PET/CT systems, radiotheranostics, and compact imaging systems.
BIS Research offers KOL-based insights, rigorous segmentation, and strategic advisory across software, hardware, and sensing tech domains.
